Brand Name: EMPAGLIFLOZIN-M
Generic Name: Empagliflozin and Metformin Hydrochloride
Available Strengths:
Empagliflozin and Metformin Hydrochloride Tablets 12.5mg+500mg/12.5mg+1000mg
Empagliflozin and Metformin Hydrochloride Tablets are a powerful combination therapy designed to improve blood glucose control in adults with Type 2 diabetes. Empagliflozin works by increasing glucose excretion through urine, while Metformin reduces hepatic glucose production and enhances insulin sensitivity. Together, they deliver superior glycemic control, reduce cardiovascular risks, support weight management, and minimize the progression of diabetic complications. Widely recommended by healthcare professionals, this combination is in high demand globally among buyers, distributors, exporters, and pharmaceutical suppliers seeking reliable, high-quality anti-diabetic medication manufactured under strict quality standards.
Capabilities Offered:
Ready dossier for both strengths in CTD/ ACTD format
Third party manufacturing services
Contract Manufacturing (CMO Services)
Formulation Development Services
Regulatory & Documentation Support
Export / Licensing Services
In addition to the products listed on our website, we possess the technical capability and infrastructure to develop and manufacture customized formulations as per your specific requirements and regulatory markets.
For business inquiries, email at sales@cooperpharma.com